查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1826981

2025年放射腫瘤學全球市場報告

Radiotherapy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，放射治療市場規模強勁成長，從2024年的73.8億美元增加至2025年的78.9億美元，複合年成長率為7.0%。預測期內的成長歸因於全球癌症發病率的上升、對非侵入性癌症治療的需求不斷成長、醫療基礎設施的不斷擴展、個性化醫療的普及以及需要癌症治療的患者數量的不斷成長。

預計未來幾年放射治療市場將強勁成長，到2029年將達到102.7億美元，年複合成長率（CAGR）為6.8%。預測期內成長的促進因素包括：對先進醫療技術的投資不斷增加、對微創治療方案的關注度不斷提高、對家庭醫療保健解決方案的需求不斷成長、對品質保證計劃的關注度不斷提高，以及針對癌症治療的全球健康計劃日益增多。預測期內的主要趨勢包括：影像導航放射治療的進步、粒子治療的進步、新型近距離放射治療技術的研發、電腦刀技術的進步以及人工智慧在治療計劃中的整合。

放射療法使用高劑量的放射線治療方法破壞癌細胞並縮小腫瘤。它通常作為獨立療法使用，或與手術和化療聯合使用，以治療多種類型的癌症。

放射治療的主要類型包括體外放射治療、內照射放射治療和全身放射治療。體外放射治療使用外部設備的高能量輻射來瞄準並摧毀癌細胞。這種治療方法治療方法多種癌症，包括攝護腺癌、乳癌、肺癌、頭頸癌、大腸癌、婦科癌、子宮頸癌和陰莖癌。它的最終用戶包括醫院和診斷實驗室、癌症治療和研究中心、學術機構以及門診手術中心。

2025年春季，美國關稅飆升及其引發的貿易摩擦對醫療保健產業產生了重大影響，尤其是基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正努力應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本，其中許多產品的國內替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力，一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，導致供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供放射腫瘤學市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的放射腫瘤學細分市場、市場趨勢和商業機會，以及在放射腫瘤學行業取得成功所需的數據。這份放射腫瘤學市場研究報告提供了您所需的一切資訊，並詳細分析了該行業的現狀和未來趨勢。

未來五年6.8%的成長率預測較先前的預測略有下降，下降了0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將增加美國的發展，從而推遲晚期癌症治療並增加放射腫瘤學支出。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，其影響也將更加廣泛。

癌症發生率的上升預計將推動放射治療市場的擴張。癌症是一種以異常細胞不受控制地生長為特徵的疾病，這些細胞會侵襲並轉移到身體的其他部位，影響各種組織和器官，並引起各種症狀。癌症發生率的上升與人口老化、生活方式的改變（包括不良飲食和缺乏運動）、大量吸煙和飲酒、環境污染以及能夠早期發現的診斷工具的進步等因素有關。放射治療在癌症治療中發揮關鍵作用，它可以精準靶向並摧毀癌細胞，縮小腫瘤並改善患者預後。例如，2024年8月，英國一家支持癌症患者的慈善機構麥克米倫癌症援助組織報告稱，英國有超過300萬人患有癌症，並預測到2025年這一數字將增至350萬，到2030年將增至400萬，到2040年將增至530萬。因此，癌症發生率的上升正在刺激放射治療市場的成長。

放射治療市場的主要企業正在優先開發創新技術，例如影像導航放射治療(IGRT)，以提高治療精度、改善患者預後並最大限度地減少對周圍健康組織的損害。 IGRT 利用先進的成像工具確保放射治療期間的精確腫瘤靶向，從而可以即時追蹤和調整腫瘤位置以提高準確性。例如，2022 年 5 月，瑞典醫療技術公司 Elekta AB 推出了下一代放射線手術系統 Elekta Esprit，可增強立體定位放射線手術的功能。該系統將多種創新技術整合到一個平台中，為治療團隊提供卓越的可視化和遠端存取。它支援靈活的工作流程選項，包括單次、分次、自適應和分階段通訊協定，從而最佳化了臨床環境中的易用性和效率。它旨在治療最具挑戰性的疾病，同時以低於 0.3 毫米的精度保護周圍的健康組織。

2024年2月，美國製藥公司百時美施貴寶收購了RayzeBio，具體金額未揭露。此次收購增強了該公司的腫瘤學產品線，使其擁有先進的放射性藥物療法，其中包括RYZ101，該藥物標靶治療胃腸道間質瘤-神經內分泌腫瘤（GEP-NETs）和早期小細胞肺癌（ES-SCLC）中的SSTR2基因。憑藉正在進行的臨床試驗和先進的生產設施，這項策略性舉措使百時美施貴寶能夠加速創新，拓展治療方案，並推動腫瘤學領域的成長。 RayzeBio是一家總部位於美國的公司，專注於開發用於治療癌症的創新放射性藥物。

放射治療市場包括提供近距離放射治療、安寧療護、質子治療和術中放射治療等服務的營業單位所獲得的收益。市場價值包括服務提供者銷售的或包含在其服務產品中的任何相關商品的價值。放射治療市場包括患者定位系統、表面導引放射治療 (SGRT)、CT 和 MRI 模擬系統以及直線加速器的銷售。此市場價值為“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球放射腫瘤學：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球放射腫瘤學市場：成長率分析
  • 全球放射腫瘤學市場表現：規模與成長，2019-2024
  • 全球放射腫瘤學市場預測：2024-2029年及2034年規模與成長
  • 全球放射腫瘤學：總目標市場（TAM）

第6章 市場細分

  • 全球放射腫瘤學市場（依治療類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 體外放射治療
  • 內部放射治療
  • 全身放射線治療
  • 全球放射腫瘤學市場：按應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 攝護腺癌
  • 乳癌
  • 肺癌
  • 頭頸癌
  • 大腸直腸癌
  • 婦科癌症
  • 子宮頸癌
  • 陰莖癌
  • 其他用途
  • 全球放射腫瘤學市場：按最終用戶、業績和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診斷實驗室
  • 癌症治療與研究中心
  • 學術研究機構
  • 門診手術中心
  • 其他最終用戶
  • 全球放射治療市場：依體外放射治療類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 強度調控放射治療（IMRT）
  • 立體定位放射治療（SBRT）
  • 3D適形放射治療（3D-CRT）
  • 質子治療
  • 影像導航放射治療（IGRT）
  • 容積調強弧形治療 (VMAT)
  • 全球放射腫瘤學市場：按內部放射治療細分（按類型）、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 近距離放射治療（高劑量率）
  • 近距離放射治療（低劑量率）
  • 術中放射治療（IORT）
  • 永久種子植入
  • 全球放射腫瘤學市場：依全身放射線治療類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 放射性同位素治療
  • 標靶放射性核素治療
  • 放射免疫治療
  • 胜肽受體放射性核種治療（PRRT）

第7章 區域和國家分析

  • 全球放射腫瘤學市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球放射腫瘤學市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 放射腫瘤學市場：競爭格局
  • 放射腫瘤學市場：公司簡介
    • Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Elekta AB
  • Accuray Incorporated
  • Ion Beam Applications SA
  • Canon Medical Systems Corporation
  • RefleXion Medical Inc.
  • Mevion Medical Systems Inc.
  • Nordion Inc.
  • Theragenics Corporation
  • RaySearch Laboratories AB
  • MIM Software Inc.
  • Vision RT Ltd.
  • Sun Nuclear Corporation
  • Provision Healthcare LLC
  • Panacea Medical Technologies Pvt. Ltd.
  • Optivus Proton Therapy Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年放射腫瘤學市場：提供新機會的國家
  • 2029年放射腫瘤學市場：細分領域帶來新機會
  • 2029年放射腫瘤學市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r34133u

Radiotherapy is a medical treatment that utilizes high doses of radiation to destroy cancer cells and shrink tumors. It is commonly used to treat various types of cancer, either as a standalone therapy or in combination with surgery and chemotherapy.

The primary types of radiotherapy include external beam radiation therapy, internal beam radiation therapy, and systemic radiation therapy. External beam radiation therapy delivers high-energy radiation from an external machine to target and destroy cancer cells. This treatment is applied to various cancers, including prostate, breast, lung, head and neck, colorectal, gynecological, cervical, and penile cancers, among others. It is used by multiple end users, such as hospitals and diagnostic labs, cancer treatment and research centers, academic institutions, and ambulatory surgery centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The radiotherapy market research report is one of a series of new reports from The Business Research Company that provides radiotherapy market statistics, including the radiotherapy industry's global market size, regional shares, competitors with a radiotherapy market share, detailed radiotherapy market segments, market trends and opportunities, and any further data you may need to thrive in the radiotherapy industry. This radiotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The radiotherapy market size has grown strongly in recent years. It will grow from $7.38 billion in 2024 to $7.89 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to an increase in the incidence of cancer cases globally, growth in demand for non-invasive cancer treatments, expansion of healthcare infrastructure, rise in adoption of personalized medicine, and rise in patient population requiring cancer treatment.

The radiotherapy market size is expected to see strong growth in the next few years. It will grow to $10.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing investment in advanced healthcare technologies, increasing focus on minimally invasive treatment options, rising demand for home-based healthcare solutions, increasing focus on quality assurance programs, and increasing global health initiatives addressing cancer care. Major trends in the forecast period include advancements in image-guided radiotherapy, advancements in particle therapy, development of novel brachytherapy techniques, advancements in cyberKnife technology, and integration of artificial intelligence in treatment planning.

The forecast of 6.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of proton therapy gantry components sourced from France and Italy, thereby delaying advanced cancer treatments and elevating radiation oncology department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of cancer is anticipated to drive the expansion of the radiotherapy market. Cancer is a disease characterized by the uncontrolled growth of abnormal cells that can invade and spread to other parts of the body, affecting various tissues and organs and leading to a wide range of symptoms. The increasing incidence of cancer is linked to factors such as an aging population, lifestyle changes including poor diet and physical inactivity, high tobacco and alcohol consumption, environmental pollution, and advancements in diagnostic tools that enable earlier detection. Radiotherapy plays a vital role in cancer treatment by precisely targeting and destroying cancerous cells, reducing tumor size, and improving patient outcomes. For example, in August 2024, Macmillan Cancer Support, a UK-based charitable organization supporting cancer patients, reported that more than 3 million people in the UK were living with cancer, with projections indicating an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the rising prevalence of cancer is fueling the growth of the radiotherapy market.

Leading companies in the radiotherapy market are prioritizing the development of innovative technologies, such as image-guided radiotherapy (IGRT), to enhance treatment precision, improve patient outcomes, and minimize damage to surrounding healthy tissues. IGRT utilizes advanced imaging tools to ensure accurate tumor targeting during radiation therapy, allowing real-time tracking and adjustments to the tumor's position for increased precision. For instance, in May 2022, Elekta AB, a Sweden-based medical technology company, introduced the Elekta Esprit, a next-generation radiosurgery system that enhances the capabilities of stereotactic radiosurgery. This system integrates multiple innovations into a single platform, offering superior visualization and remote accessibility for treatment teams. It supports flexible workflow options, including single-session, fractionated, adaptive, or staged protocols, optimizing ease of use and efficiency in clinical settings. With an accuracy of less than 0.3 mm, the system is designed to treat even the most challenging targets while preserving surrounding healthy tissues.

In February 2024, Bristol Myers Squibb, a US-based pharmaceutical company, acquired RayzeBio Inc. for an undisclosed amount. This acquisition strengthens its oncology pipeline with advanced radiopharmaceutical therapeutics, including RYZ101, which targets SSTR2 in GEP-NETs and ES-SCLC. With ongoing clinical trials and a state-of-the-art manufacturing facility, this strategic move enables Bristol Myers Squibb to accelerate innovation, expand treatment options, and drive growth in the oncology sector. RayzeBio Inc. is a US-based company specializing in the development of innovative radiopharmaceuticals for cancer treatment.

Major players in the radiotherapy market are Hitachi Ltd., Koninklijke Philips N.V., GE Healthcare Technologies Inc., Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Ion Beam Applications S.A, Canon Medical Systems Corporation, RefleXion Medical Inc., Mevion Medical Systems Inc., Nordion Inc., Theragenics Corporation, RaySearch Laboratories AB, MIM Software Inc., Vision RT Ltd., Sun Nuclear Corporation, Provision Healthcare LLC, Panacea Medical Technologies Pvt. Ltd., Optivus Proton Therapy Inc., Perspective Therapeutics Inc., GT Medical Technologies Inc., ProTom International Inc.

North America was the largest region in the radiotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in radiotherapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the radiotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiotherapy market includes revenues earned by entities by providing services such as brachytherapy, palliative radiotherapy, proton therapy, and intraoperative radiotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The radiotherapy market consists of sales of patient positioning systems, surface-guided radiation therapy systems (SGRT), CT and MRI simulation systems, and linear accelerators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiotherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The radiotherapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Therapy Type: External Beam Radiation Therapy; Internal Beam Radiation Therapy; Systemic Radiation Therapy
  • 2) By Application: Prostate Cancer; Breast Cancer; Lung Cancer; Head And Neck Cancer; Colorectal Cancer; Gynecological Cancer; Cervical Cancer; Penile Cancer; Other Applications
  • 3) By End-User: Hospitals And Diagnostic Laboratories; Cancer Treatment And Research Centers; Academic Research Organizations; Ambulatory Surgery Centers; Other End-Users
  • Subsegments:
  • 1) By External Beam Radiation Therapy: Intensity-Modulated Radiation Therapy (IMRT); Stereotactic Body Radiation Therapy (SBRT); 3D Conformal Radiation Therapy (3D-CRT); Proton Beam Therapy; Image-Guided Radiation Therapy (IGRT); Volumetric Modulated Arc Therapy (VMAT)
  • 2) By Internal Beam Radiation Therapy: Brachytherapy (High-Dose Rate); Brachytherapy (Low-Dose Rate); Intraoperative Radiation Therapy (IORT); Permanent Seed Implants
  • 3) By Systemic Radiation Therapy: Radioisotope Therapy; Targeted Radionuclide Therapy; Radioimmunotherapy; Peptide Receptor Radionuclide Therapy (PRRT)
  • Companies Mentioned: Hitachi Ltd.; Koninklijke Philips N.V.; GE Healthcare Technologies Inc.; Sumitomo Heavy Industries Ltd.; Varian Medical Systems Inc.; Elekta AB; Accuray Incorporated; Ion Beam Applications S.A; Canon Medical Systems Corporation; RefleXion Medical Inc.; Mevion Medical Systems Inc.; Nordion Inc.; Theragenics Corporation; RaySearch Laboratories AB; MIM Software Inc.; Vision RT Ltd.; Sun Nuclear Corporation; Provision Healthcare LLC; Panacea Medical Technologies Pvt. Ltd.; Optivus Proton Therapy Inc.; Perspective Therapeutics Inc.; GT Medical Technologies Inc.; ProTom International Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiotherapy Market Characteristics

3. Radiotherapy Market Trends And Strategies

4. Radiotherapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Radiotherapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Radiotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Radiotherapy Market Growth Rate Analysis
  • 5.4. Global Radiotherapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Radiotherapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Radiotherapy Total Addressable Market (TAM)

6. Radiotherapy Market Segmentation

  • 6.1. Global Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • External Beam Radiation Therapy
  • Internal Beam Radiation Therapy
  • Systemic Radiation Therapy
  • 6.2. Global Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head And Neck Cancer
  • Colorectal Cancer
  • Gynecological Cancer
  • Cervical Cancer
  • Penile Cancer
  • Other Applications
  • 6.3. Global Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Diagnostic Laboratories
  • Cancer Treatment And Research Centers
  • Academic Research Organizations
  • Ambulatory Surgery Centers
  • Other End-Users
  • 6.4. Global Radiotherapy Market, Sub-Segmentation Of External Beam Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Stereotactic Body Radiation Therapy (SBRT)
  • 3D Conformal Radiation Therapy (3D-CRT)
  • Proton Beam Therapy
  • Image-Guided Radiation Therapy (IGRT)
  • Volumetric Modulated Arc Therapy (VMAT)
  • 6.5. Global Radiotherapy Market, Sub-Segmentation Of Internal Beam Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Brachytherapy (High-Dose Rate)
  • Brachytherapy (Low-Dose Rate)
  • Intraoperative Radiation Therapy (IORT)
  • Permanent Seed Implants
  • 6.6. Global Radiotherapy Market, Sub-Segmentation Of Systemic Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radioisotope Therapy
  • Targeted Radionuclide Therapy
  • Radioimmunotherapy
  • Peptide Receptor Radionuclide Therapy (PRRT)

7. Radiotherapy Market Regional And Country Analysis

  • 7.1. Global Radiotherapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Radiotherapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Radiotherapy Market

  • 8.1. Asia-Pacific Radiotherapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Radiotherapy Market

  • 9.1. China Radiotherapy Market Overview
  • 9.2. China Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Radiotherapy Market

  • 10.1. India Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Radiotherapy Market

  • 11.1. Japan Radiotherapy Market Overview
  • 11.2. Japan Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Radiotherapy Market

  • 12.1. Australia Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Radiotherapy Market

  • 13.1. Indonesia Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Radiotherapy Market

  • 14.1. South Korea Radiotherapy Market Overview
  • 14.2. South Korea Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Radiotherapy Market

  • 15.1. Western Europe Radiotherapy Market Overview
  • 15.2. Western Europe Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Radiotherapy Market

  • 16.1. UK Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Radiotherapy Market

  • 17.1. Germany Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Radiotherapy Market

  • 18.1. France Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Radiotherapy Market

  • 19.1. Italy Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Radiotherapy Market

  • 20.1. Spain Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Radiotherapy Market

  • 21.1. Eastern Europe Radiotherapy Market Overview
  • 21.2. Eastern Europe Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Radiotherapy Market

  • 22.1. Russia Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Radiotherapy Market

  • 23.1. North America Radiotherapy Market Overview
  • 23.2. North America Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Radiotherapy Market

  • 24.1. USA Radiotherapy Market Overview
  • 24.2. USA Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Radiotherapy Market

  • 25.1. Canada Radiotherapy Market Overview
  • 25.2. Canada Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Radiotherapy Market

  • 26.1. South America Radiotherapy Market Overview
  • 26.2. South America Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Radiotherapy Market

  • 27.1. Brazil Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Radiotherapy Market

  • 28.1. Middle East Radiotherapy Market Overview
  • 28.2. Middle East Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Radiotherapy Market

  • 29.1. Africa Radiotherapy Market Overview
  • 29.2. Africa Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Radiotherapy Market Competitive Landscape And Company Profiles

  • 30.1. Radiotherapy Market Competitive Landscape
  • 30.2. Radiotherapy Market Company Profiles
    • 30.2.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Radiotherapy Market Other Major And Innovative Companies

  • 31.1. Elekta AB
  • 31.2. Accuray Incorporated
  • 31.3. Ion Beam Applications S.A
  • 31.4. Canon Medical Systems Corporation
  • 31.5. RefleXion Medical Inc.
  • 31.6. Mevion Medical Systems Inc.
  • 31.7. Nordion Inc.
  • 31.8. Theragenics Corporation
  • 31.9. RaySearch Laboratories AB
  • 31.10. MIM Software Inc.
  • 31.11. Vision RT Ltd.
  • 31.12. Sun Nuclear Corporation
  • 31.13. Provision Healthcare LLC
  • 31.14. Panacea Medical Technologies Pvt. Ltd.
  • 31.15. Optivus Proton Therapy Inc.

32. Global Radiotherapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiotherapy Market

34. Recent Developments In The Radiotherapy Market

35. Radiotherapy Market High Potential Countries, Segments and Strategies

  • 35.1 Radiotherapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Radiotherapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Radiotherapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer